Similarly, co-culture with overweight or obese adipocytes and treatment with bortezomib increased ABCC1 gene expression 90-fold (overweight) or 70-fold (obese) compared to non-co-cultured MM cells treated with bortezomib. This evidence concerns the gene ABCC1 and Miyoshi myopathy.